The global amniocentesis needle market was valued at USD 170.5 million in 2024 and has been forecast to expand at a CAGR of 3.2% to end up at USD 239.8 million by 2035. The increasing demand for prenatal genetic testing being driven by a growing median age for first-time mothers as well as greater awareness of genetic disorders is dominating the amniocentesis needle market. Several...